Literature DB >> 31210413

Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptions.

Robin Reschke1, Maja Mockenhaupt2, Jan-Christoph Simon1, Mirjana Ziemer1.   

Abstract

Entities:  

Year:  2019        PMID： 31210413     DOI： 10.1111/ddg.13876

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  3 in total

Review 1.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13

2.  Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases.

Authors:  Saskia Ingen-Housz-Oro; Brigitte Milpied; Marine Badrignans; Cristina Carrera; Yannick S Elshot; Benoit Bensaid; Sonia Segura; Zoé Apalla; Alina Markova; Delphine Staumont-Sallé; Ignasi Marti-Marti; Priscila Giavedoni; Ser-Ling Chua; Anne-Sophie Darrigade; Frédéric Dezoteux; Michela Starace; Ana Clara Torre; Julia Riganti; Nicolas de Prost; Bénédicte Lebrun-Vignes; Olivia Bauvin; Sarah Walsh; Nicolas Ortonne; Lars E French; Vincent Sibaud
Journal:  Melanoma Res       Date:  2022-03-29       Impact factor: 3.199

3.  Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.

Authors:  Isabella Pospischil; Wolfram Hoetzenecker
Journal:  J Dtsch Dermatol Ges       Date:  2021-11       Impact factor: 5.231
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.